First Trust Indxx Global Mdcl Dvcs ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
First Trust Indxx Global Medical Devices ETF MDEV
Morningstar’s Analysis MDEV
Will MDEV outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MDEV management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MDEV’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
West Pharmaceutical Services Inc | 2.68 | 50,426 | Healthcare |
LivaNova PLC | 2.65 | 49,834 | Healthcare |
Demant AS | 2.58 | 48,445 | Healthcare |
Baxter International Inc | 2.50 | 46,935 | Healthcare |
DexCom Inc | 2.39 | 44,920 | Healthcare |
Edwards Lifesciences Corp | 2.38 | 44,733 | Healthcare |
Waters Corp | 2.36 | 44,346 | Healthcare |
Revvity Inc | 2.36 | 44,334 | Healthcare |
Agilent Technologies Inc | 2.34 | 43,892 | Healthcare |
Straumann Holding AG | 2.30 | 43,274 | Healthcare |